[The first experience of the use the Russian Β-interferon-1b biosimilar (infibeta) in the daily practice of the Moscow Center of Multiple Sclerosis].
Year: 2013
Type: article
Study design: Observational Study
Source: PubMed
Authors: E V Popova, A N Boĭko, M V Davydovskaia, T L Demina, T M Kukel', N Iu Lashch, N F Popova, N V Khachanova, S G Shchur, E I Gusev
Language: Russian
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W303604298